PhRMA v. HHS
Executive Summary
Michigan Medicaid supplemental rebate program upheld by D.C. federal court March 28. The court heard oral arguments on the Pharmaceutical Research & Manufacturers of America's challenge of the program Aug. 28, 2002 and Feb. 5 (1"The Pink Sheet" Feb. 10, p. 16)...
You may also be interested in...
Michigan Rx rebate requirements upheld
Michigan Medicaid may require prior authorization for drugs that do not provide rebates to non-Medicaid programs, D.C. federal appeals court affirms April 2. The Pharmaceutical Research & Manufacturers of America's lawsuit against the state argued the policy was not in the "best interest" of Medicaid recipients; the lower court also ruled against PhRMA (1"The Pink Sheet" March 31, 2003, In Brief). The 2appellate court ruling cited the Supreme Court's rejection of PhRMA's challenge to a similar Maine program last year (3"The Pink Sheet" May 26, 2003, p. 23). [Editor's Note: A version of this story first appeared in 4"The Pink Sheet" DAILY April 2. Visit our website, www.ThePinkSheetDAILY.com, to sign up for a free trial.]...
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.